Methyl 4-bromo-2-fluoro-3-methylbenzoate, 97.0%, 5g

tert-Butyl 4-amino-4-cyanopiperidine-1-carboxylate, 95.0%, 1g

Ethyl 4-bromothiophene-3-carboxylate, 97%, 250mg

8-BROMO-2-CHLOROQUINOLINE-4-CARBOXYLIC ACID, 95%, 250mg

[(8-methylimidazo[1,2-a]pyridin-2-yl)methyl]amine dihydrochloride, 95.0%, 250mg

N-Methyl-L-aspartic acid, 95.0%, 500g

Sclareolide, 95.0%, 10g

7-(Diethylamino)-3-(2-thienyl)coumarin>98.0%(HPLC)(T)5g

Elagolix sodium, 100mg

ETHYL 1-CYCLOPROPYL-6,7-DIFLUORO-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLATE, 97.0%, 10g

Ethyl 5-fluoropyrimidine-2-carboxylate, 98%, 1g

Ethyl 4-amino-3-(trifluoromethyl)benzoate, 95+%, 250mg

Hexane (isomers), min. 95% (isomers), for synthesis, 2.5 L, glass packaging